Suppr超能文献

多发性硬化症诊断中的视网膜双眼差异与萎缩进展。

Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics.

机构信息

Neurology, MS Center and Neuro-ophthalmology Expertise Center, Amsterdam Neuroscience, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, Netherlands

Ophthalmology, Neuro-ophthalmology Expertise Center, Amsterdam Neuroscience, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, Netherlands.

出版信息

J Neurol Neurosurg Psychiatry. 2022 Feb;93(2):216-219. doi: 10.1136/jnnp-2021-327468. Epub 2021 Nov 11.

Abstract

BACKGROUND

The visual system could be included in the diagnostic criteria for multiple sclerosis (MS) to demonstrate dissemination in space (DIS) and dissemination in time (DIT).

OBJECTIVE

To investigate the diagnostic value of retinal asymmetry in MS.

METHODS

A prospective, longitudinal study in individuals with MS (n=151) and healthy controls (n=27). Optical coherence tomography (OCT) was performed at 0, 2 and 4 years. Macular ganglion cell and inner plexiform layer (mGCIPL) thickness was determined as well as measures for retinal asymmetry: the inter-eye percentage difference (IEPD) and inter-eye absolute difference (IEAD). Receiver operator characteristics curves were plotted and the area under the curve (AUC) was calculated for group comparisons of the mGCIPL, IEPD, IEAD and atrophy rates.

RESULTS

The diagnostic accuracy of both the IEPD and IEAD for differentiating bilateral and unilateral MS optic neuritis was high and stable over time (AUCs 0.88-0.93). The IEPD slightly outperformed the IEAD. Atrophy rates showed low discriminatory abilities for differentiating MS from controls (AUC 0.49-0.58).

CONCLUSION

The inter-eye differences of the mGCIPL have value for demonstration of DIS but in individuals with longstanding MS not for DIT. This may be considered as a test to detect DIS in future diagnostic criteria. Validation in a large prospective study in people presenting with symptoms suggestive of MS is required.

摘要

背景

视觉系统可被纳入多发性硬化症(MS)的诊断标准,以证明在空间上的弥散(DIS)和时间上的弥散(DIT)。

目的

探讨视网膜不对称在多发性硬化症中的诊断价值。

方法

对 151 例多发性硬化症患者(MS)和 27 例健康对照者进行前瞻性、纵向研究。在 0、2 和 4 年时进行光学相干断层扫描(OCT)。测量黄斑神经节细胞和内丛状层(mGCIPL)的厚度以及视网膜不对称的指标:眼间百分比差异(IEPD)和眼间绝对差异(IEAD)。绘制受试者工作特征曲线,并计算 mGCIPL、IEPD、IEAD 和萎缩率的组间比较曲线下面积(AUC)。

结果

IEPD 和 IEAD 对区分双侧和单侧 MS 视神经炎的诊断准确性高且稳定,时间上 AUC 值为 0.88-0.93。IEPD 略优于 IEAD。萎缩率区分 MS 与对照组的能力较低(AUC 为 0.49-0.58)。

结论

mGCIPL 的眼间差异对证明 DIS 有价值,但在 MS 患者中不能用于证明 DIT。这可被视为未来诊断标准中检测 DIS 的一项检测。需要在有 MS 症状的大样本前瞻性研究中进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0009/8785044/c5e419af8147/jnnp-2021-327468f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验